Scott Reents
Director of Finance/CFO bij TOBIRA THERAPEUTICS INC
Vermogen: 3 M $ op 31-03-2024
Profiel
Scott T.
Reents is currently the President & Director at Allergan, Inc. and Oculeve, Inc. He is also the Chief Financial Officer & Executive Vice President at AbbVie, Inc. and the Chief Financial Officer at Tobira Therapeutics, Inc. Previously, he worked as the Vice President-Tax at Abbott Laboratories.
Mr. Reents completed his undergraduate degree at the University of Nebraska and holds graduate and MBA degrees from the University of Washington.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ABBVIE, INC.
0.00% | 28-02-2024 | 15 431 ( 0.00% ) | 3 M $ | 31-03-2024 |
Actieve functies van Scott Reents
| Bedrijven | Functie | Begin |
|---|---|---|
| TOBIRA THERAPEUTICS INC | Director of Finance/CFO | - |
| ABBVIE INC. | Director of Finance/CFO | 23-06-2022 |
| ALLERGAN, INC. | President | - |
Oculeve, Inc.
 Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | President | - |
Eerdere bekende functies van Scott Reents
| Bedrijven | Functie | Einde |
|---|---|---|
| ABBOTT LABORATORIES | Comptroller/Controller/Auditor | - |
Opleiding van Scott Reents
| University of Nebraska | Undergraduate Degree |
| University of Washington | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| ABBVIE INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Oculeve, Inc.
Oculeve, Inc. Medical SpecialtiesHealth Technology Oculeve, Inc. develops devices for dry eye disease treatment. The company was founded by D. Michael Ackermann, Brandon M. Felkins, Garrett Cale Smith and Victor Wayne McCray in 2011 and is headquartered in Parsippany, NJ. | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
